TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T95286	Myelin-associated glycoprotein	B32EVI	Sodium;(2S,4S,5R,6R)-5-acetamido-2-[(2R,3R,4S,5S,6R)-2-[(2R,3R,4R,5R,6S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-phenylmethoxyoxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate	Investigative	56677195	C32H47N2NaO19	786.7	CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)[O-])O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H]([C@H](O[C@@H]([C@@H]3O)CO)OCC4=CC=CC=C4)NC(=O)C)CO)O)O.[Na+]	IC50 = 52000 nM	Poor binder
T95286	Myelin-associated glycoprotein	BKU81F	(2R,4S,5R,6R)-6-[(1R,2R)-1,2-Dihydroxy-3-[[2-[4-(4-hydroxyphenyl)phenyl]acetyl]amino]propyl]-4-hydroxy-5-[(2-hydroxyacetyl)amino]-2-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-(4-methoxyphenoxy)oxan-2-yl]methoxy]oxane-2-carboxylic acid	Investigative	25140736	C38H46N2O17	802.8	COC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO[C@@]3(C[C@@H]([C@H]([C@@H](O3)[C@@H]([C@@H](CNC(=O)CC4=CC=C(C=C4)C5=CC=C(C=C5)O)O)O)NC(=O)CO)O)C(=O)O)O)O)O	IC50 = 136000 nM	Poor binder
T95286	Myelin-associated glycoprotein	BR7OX6	(2R,4S,5R,6R)-6-[(1R,2R)-1,2-Dihydroxy-3-[[2-[4-(4-hydroxyphenyl)phenyl]acetyl]amino]propyl]-4-hydroxy-5-[(2-hydroxyacetyl)amino]-2-[(4-phenylphenyl)methoxy]oxane-2-carboxylic acid	Investigative	53322630	C38H40N2O11	700.7	C1[C@@H]([C@H]([C@@H](O[C@]1(C(=O)O)OCC2=CC=C(C=C2)C3=CC=CC=C3)[C@@H]([C@@H](CNC(=O)CC4=CC=C(C=C4)C5=CC=C(C=C5)O)O)O)NC(=O)CO)O	IC50 = 164000 nM	Poor binder
T95286	Myelin-associated glycoprotein	BY2A3I	Benzyl 3,5,9-trideoxy-5-glycolamido-9-(4''-hydroxy-4-biphenyl)acetamido-D-glycero-alpha-D-galacto-2-nonulopyranosidonic acid	Investigative	53317637	C32H36N2O11	624.6	C1[C@@H]([C@H]([C@@H](O[C@]1(C(=O)O)OCC2=CC=CC=C2)[C@@H]([C@@H](CNC(=O)CC3=CC=C(C=C3)C4=CC=C(C=C4)O)O)O)NC(=O)CO)O	IC50 = 171000 nM	Poor binder